Sibel Health and LookDeep Health have announced a strategic partnership that pairs continuous, clinical-grade wearable vital signs monitoring with real-time bedside AI to give care teams a more complete picture of patient condition across emergency departments, general inpatient units, and hospital-to-home recovery. The collaboration addresses a persistent gap in patient monitoring outside the ICU, where most hospitalized patients are still observed through periodic spot checks, an approach that medical research has consistently shown leaves critical clinical events undetected.
HotSpot Take
When continuous vitals data meets real-time bedside AI context, threshold-only alarms give way to situation-aware intelligence, and that distinction can determine clinical outcomes.
The Problem with Spot Checks
For decades, intermittent vital signs measurement every four to six hours has been the standard of care on general medical and surgical wards. The clinical limitations of that model are now well-documented.
A 2025 propensity-matched analysis published in the Journal of Medical Internet Research examined 7,971 medical ward patients and found that those receiving intermittent monitoring had nearly three times the odds of in-hospital mortality or ICU transfer compared with patients receiving continuous wireless monitoring (odds ratio 2.79; p<0.001). A parallel study published in the British Journal of Anaesthesiology reported that 79% of hypotensive episodes and 83% of desaturation events in general ward patients occurred outside the windows of intermittent spot checks, meaning standard monitoring protocols missed the vast majority of these potentially life-threatening events.
These gaps are compounded by workforce pressures that make consistent manual observation increasingly difficult. Projections estimate a shortfall of more than 78,000 full-time registered nurses in 2025, with hospital RN turnover running at approximately 16% annually, according to the 2025 NSI National Health Care Retention and RN Staffing Report. Add alarm fatigue to the equation: a 2024 survey found that 82.9% of nurses frequently or occasionally felt overwhelmed by the volume of clinical alarms, and the case for more intelligent, context-aware monitoring becomes difficult to dismiss.
Combining Continuous Vitals with Bedside AI Context
The Sibel-LookDeep integration pairs two complementary technologies. Sibel’s ANNE® One platform is an FDA-cleared wearable monitoring system that delivers continuous, clinical-grade measurement of oxygen saturation, heart rate, respiratory rate, continuous noninvasive blood pressure, and ECG. The ANNE® One is among the few wearable monitoring platforms compliant with the IEEE 11073 SDC standard for point-of-care medical device interoperability, a specification designed to enable manufacturer-independent, bidirectional data exchange between medical devices and hospital information systems without requiring proprietary integration work.
LookDeep Health’s aimee™ platform brings a different capability: real-time visual and audio context at the bedside. Using computer vision, audio understanding, and natural language processing, aimee™ observes what is happening in the patient’s room (patient position, movement, behavior, and level of engagement) and pairs that context with incoming physiologic data. The result is a monitoring picture that reflects not only what the numbers show, but what the patient actually looks like in the moment those numbers appear.
That contextual layer matters clinically. A rising heart rate in a patient who is sleeping quietly suggests a different response than the same reading in a patient who is agitated, attempting to get out of bed, or showing signs of labored breathing. Without bedside context, every threshold alert looks the same. With it, care teams can better calibrate urgency, escalating earlier when the combination of signals warrants it, and reducing unnecessary interruptions when it does not.
Importantly, aimee™ supports clinician-directed vigilance. Nurses can instruct aimee™ to watch for specific conditions or behaviors on individual patients: a fall risk patient who tends to attempt to get up unassisted, a post-surgical patient whose respiratory pattern warrants monitoring, a patient transitioning toward discharge whose activity level indicates readiness. The AI delivers concise, workflow-aligned updates rather than indiscriminate alerts, reducing the alarm burden that contributes to fatigue and delayed response.
“The breakthrough comes when those signals are paired with real-time context and turned into timely, actionable insight.” – Steve Xu, MD, CEO and Co-Founder, Sibel Health
“Better health data for all means making continuous sensing reliable and usable across the full continuum, from the ED to the inpatient setting and into recovery at home,” said Steve Xu, MD, CEO and Co-Founder of Sibel Health. “The breakthrough comes when those signals are paired with real-time context and turned into timely, actionable insight.”
From Inpatient to Hospital-at-Home
The partnership is designed to follow patients across care transitions, not just individual units. The combined platform supports ED monitoring, inpatient acuity levels including med-surg and step-down settings, and the increasingly important hospital-to-home recovery phase, where monitoring continuity typically drops off entirely.
That continuity carries real clinical significance. A feasibility study published in the Patient Safety journal found that oxygen desaturation below 88% was observed in 92% of patients monitored for four days following hospital discharge, events that would go undetected without continuous wearable monitoring. As health systems pursue strategies to reduce avoidable readmissions, extending meaningful monitoring into the recovery period at home represents a tangible intervention point.
“Together, we’re enabling dramatically better, more sustainable care for every patient.” – Narinder Singh, CEO & Founder, LookDeep Health
“The future isn’t inside of any app; it is a unified, always-on patient experience that adapts and engages as care changes in the physical world of patients and caregivers,” said Narinder Singh, CEO and Co-Founder of LookDeep Health. “Together, we’re enabling dramatically better, more sustainable care for every patient.”
Nexus Bedside, a clinical implementation partner that works with hospitals to operationalize new care models, facilitated the collaboration. “We brought Sibel and LookDeep together because the combination is uniquely powerful: continuous vitals plus real-time bedside context and engagement,” said Akram Boutros, MD, CEO and Co-Founder of Nexus Bedside.
LookDeep’s aimee™ has been the subject of peer-reviewed AI validation research, with vision AI models achieving F1 scores exceeding 0.95 for critical hospital objects including patients and beds, even in low-light conditions. The company introduced aimee™ as its AI-native hospital platform in 2025.
Open by Design: The Case Against Lock-In
One of the more strategically notable aspects of the Sibel-LookDeep partnership is its explicit commitment to interoperability over proprietary dependency. The collaboration is structured so that health systems can deploy the integrated solution while preserving the flexibility to connect other devices, software platforms, and clinical workflows, without being constrained by a closed ecosystem.
Sibel’s IEEE 11073 SDC compliance is central to that promise. The SDC standard, developed through the IEEE in coordination with the FDA and international health informatics bodies, defines a service-oriented architecture that enables point-of-care medical devices from different manufacturers to exchange data bidirectionally and securely. According to the National Institute of Standards and Technology, the lack of interoperability between medical devices is a documented source of preventable medical errors and operational inefficiencies. SDC compliance directly addresses that risk, enabling Sibel’s wearable data to integrate with existing hospital monitoring systems, EHRs, and third-party platforms without requiring proprietary gateways.
For hospital technology leaders navigating a crowded patient monitoring market, the lock-in question is not abstract. The capital cost of replacing monitoring infrastructure, combined with the integration burden of proprietary platforms, has created meaningful inertia in how hospitals approach technology selection. The Sibel-LookDeep positioning (deploy now, integrate later, swap components as needs evolve) is designed to lower that barrier and reduce long-term switching costs.
LookDeep further differentiates on the AI validation front. The company’s computer vision platform is, according to the release, the only solution in the category with peer-reviewed AI, a meaningful credential as scrutiny of healthcare AI performance claims intensifies across the industry.
Availability
The LookDeep and Sibel integration is currently in place and will be introduced first through coordinated deployments with a limited number of health systems, with broader availability planned thereafter. Hospital leaders interested in learning more can contact press@lookdeep.health or contact@sibelhealth.com.
For patients outside the ICU, the combination of continuous physiologic data and real-time bedside intelligence offers something the current standard of care does not: the ability to see meaningful change as it is happening, in the context of how the patient is actually doing, and to act before that change becomes a crisis.
— This original article was created with AI support.
